Stocklytics Platform
Asset logo for symbol DVAX
Dynavax Technologies
DVAX68
$12.74arrow_drop_down0.46%-$0.06
Asset logo for symbol DVAX
DVAX68

$12.74

arrow_drop_down0.46%

Income Statement (DVAX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT$8.02M$16.60M-$9.80M$2.68M$12.96M
EBITDA$10.08M$18.58M-$7.85M$4.64M$14.83M
gross Profit$67.54M$61.81M$39.82M$46.90M$56.28M
NET Income$17.59M$11.38M-$8.72M$219.00K$14.29M
total Revenue$80.63M$73.79M$50.79M$55.59M$69.51M

Balance Sheet (DVAX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt$130.83M$142.78M$124.06M$106.63M$98.58M
stockholders Equity$681.42M$642.84M$618.48M$622.07M$604.91M
total Assets$1.06B$1.01B$986.56M$997.09M$972.93M
total Debt$250.16M$255.28M$256.10M$256.91M$253.09M
total Liabilities$380.56M$373.47M$368.08M$375.02M$368.01M

Cash Flow (DVAX)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow$2.47M-$1.41M-$4.20M$1.77M$2.99M
free Cash Flow$18.12M$9.93M-$17.42M$12.04M$30.78M
investing Cash Flow-----$106.07M
operating Cash Flow$19.46M$10.71M-$16.67M$13.76M$31.12M

Dynavax Technologies (DVAX) Financials

Dynavax Technologies Corp (DVAX) is a biopharmaceutical company that develops and commercializes novel vaccines and immunotherapies. The company's income statement reflects its financial performance over a given period. It provides a detailed breakdown of the company's revenue, expenses, and net income. By analyzing the income statement, investors can gain insights into the company's profitability and overall financial health.
EBIT (Earnings Before Interest and Taxes) is a measure of a company's operating profitability. It represents the company's earnings before factoring in interest expenses and taxes. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a similar measure but also excludes depreciation and amortization expenses. These metrics are important for evaluating a company's operational efficiency and its ability to generate profits from its core business operations.
Gross profit represents the revenue that remains after deducting the cost of goods sold. It reflects the profitability of the company's primary business activities. Net income from stockholders refers to the earnings that the company distributes to its stockholders after deducting all expenses and taxes. These figures are crucial for assessing the company's financial performance and its ability to reward its shareholders.
Total revenue is a measure of the company's overall sales during a given period. It includes revenue from all sources, such as product sales, licensing agreements, and royalties. This figure gives investors an overview of the company's revenue-generating activities and its performance in the market.
The balance sheet provides a snapshot of the company's financial position at a specific point in time. It presents the company's assets, liabilities, and stockholders' equity. Key components of the balance sheet include cash equivalents, net debt, stockholders' equity, total assets, total debt, and total liabilities.
Cash equivalents are highly liquid assets that can be easily converted into cash. They include treasury bills, short-term government bonds, and highly liquid money market instruments. Net debt is the difference between a company's total debt and its cash equivalents. Stockholders' equity represents the company's net worth and is calculated by subtracting total liabilities from total assets.
Total assets include all of the company's resources, both tangible and intangible. It encompasses cash, investments, property, equipment, and intellectual property. Total debt represents the company's outstanding obligations, including long-term debt, leases, and other contractual liabilities. Total liabilities include all of the company's financial obligations, including debt, accounts payable, and accrued expenses.
Cash flow is a measure of the company's cash inflows and outflows. It reflects the company's ability to generate cash from its operating activities, invest in its business, and finance its operations. Operating cash flow represents the cash generated by the company's core business activities, while investing cash flow reflects the cash used for investments in assets. Financing cash flow represents the cash used for debt repayment, dividend payments, and stock repurchases.
Free cash flow is a measure of the company's cash available for distribution to its investors. It is calculated by subtracting capital expenditures from operating cash flow. Free cash flow is an important indicator of a company's financial health and its ability to generate excess cash for growth or dividend payments.
add Dynavax Technologies to watchlist

Keep an eye on Dynavax Technologies

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level